This is an excerpt from the original initial Phase IIb AIPAC results way back in March 25, 2020.
"AIPAC Principal Investigator, Hans Wildiers of University Hospitals Leuven, Leuven, Belgium, said: “I am
pleased to see this innovative chemo-immunotherapy approach in AIPAC is well tolerated by patients, while
showing a numerically (non-significant) higher progression free survival rate compared to chemotherapy
alone."
Which I guess speaks to the statistical significance of these results...
- Forums
- ASX - By Stock
- Ann: New & significant data from AIPAC phase 2b trial in MBC
This is an excerpt from the original initial Phase IIb AIPAC...
-
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
DVP
Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
-0.045(13.2%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
33.0¢ | 33.0¢ | 29.5¢ | $1.468M | 4.740M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 37350 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 79295 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5350 | 0.295 |
19 | 506029 | 0.290 |
15 | 351834 | 0.285 |
21 | 1311059 | 0.280 |
4 | 164169 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 79295 | 3 |
0.305 | 25806 | 1 |
0.310 | 55806 | 2 |
0.315 | 58064 | 2 |
0.320 | 125806 | 2 |
Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
DVP
Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
IMM (ASX) Chart |